EGFR and non-small cell lung carcinoma: Overexpression of the epidermal growth factor receptor (EGFR/HER1) is implicated in several cancers, including non-small-cell lung cancer and head and neck squamous cell carcinoma, making EGFR a well-established target for anti-cancer therapies (46–48).